BioXcel Therapeutics (BTAI) Interest Coverage Ratio Growth (1y) (2019 - 2026)
BioXcel Therapeutics (BTAI) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -14.91% |
| 10 | BioXcel Therapeutics | 20.59 Mn | 20.59 Mn | -77,000.00 | 3.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.72% |
| Dec 31, 2025 | -164.29% |
| Sep 30, 2025 | 10.32% |
| Jun 30, 2025 | 19.68% |
| Mar 31, 2025 | 62.25% |
| Dec 31, 2024 | 157.26% |
| Sep 30, 2024 | 38.84% |
| Jun 30, 2024 | 17.82% |
| Mar 31, 2024 | -371.95% |
| Dec 31, 2023 | -1,321.96% |
| Sep 30, 2023 | -244.57% |
| Jun 30, 2023 | -271.11% |
| Mar 31, 2023 | -110.48% |
| Dec 31, 2022 | 99.99% |
| Sep 30, 2022 | -375.52% |
| Jun 30, 2022 | 99.91% |
| Mar 31, 2022 | -158.63% |
| Dec 31, 2021 | 17.43% |
| Sep 30, 2021 | -82.37% |
| Jun 30, 2021 | -1,174,555.54% |